NYSE Euronext (NYX) today announced trading volumes for its
global derivatives and cash equities exchanges for May 20131.
Global derivatives average daily volume (“ADV”) of 7.6 million
contracts, excluding Bclear in May 2013 increased 3.5% compared to
May 2012 and increased 8.2% from April 2013. U.S. equity options
volumes remained strong in May 2013 increasing 3.4% compared to May
2012 and increasing 1.2% sequentially. ADV in U.S. cash equities
declined 19.2% year-over-year and decreased 1.8% month-over-month.
European cash equities ADV in May 2013 decreased 12.9% compared to
May 2012 and decreased 6.1% from April 2013 levels.
Highlights
- NYSE Euronext global derivatives ADV in
May 2013 of 7.6 million contracts, excluding Bclear increased 3.5%
compared to May 2012 and increased 8.2% from April 2013
levels.
- NYSE Euronext European derivatives
products ADV in May 2013 of 3.2 million contracts, excluding
Bclear, increased 4.4% compared to May 2012, and increased 19.8%
from April 2013 levels. Including Bclear, NYSE Liffe’s trade
administration and clearing service for OTC products, European
derivatives ADV decreased 21.8% compared to May 2012 but increased
12.5% from April 2013.
- NYSE Euronext U.S. equity options (NYSE
Arca and NYSE Amex) ADV of 4.3 million contracts in May 2013
increased 3.4% compared to May 2012 levels and increased by 1.2%
from April 2013 levels. NYSE Euronext’s U.S. options exchanges
accounted for 27.2% of total U.S. consolidated equity options
trading in May 2013, down from 28.0% in April 2013.
- NYSE Liffe U.S. ADV of approximately
50,000 contracts in May 2013 decreased from 68,300 contracts in May
2012 but increased from 47,100 contracts in April 2013.
- NYSE Euronext European cash products
ADV of 1.4 million transactions in May 2013 decreased 12.9%
compared to May 2012, and decreased 6.1% compared to April
2013.
- NYSE Euronext U.S. cash products (NYSE,
NYSE Arca and NYSE MKT) handled ADV of 1.5 billion shares in May
2013 a decrease of 19.2% compared to May 2012, and decreased 1.8%
compared to April 2013. NYSE Euronext’s Tape A matched market share
in May 2013 was 30.0%, down from 31.9% in May 2012 and down from
30.2% in April 2013.
Please click here for the Monthly Transaction Activity Data
Table.
_____________________________
1 All NYSE Euronext derivatives
transactions count buy and sell orders together as a single
transaction. NYSE Euronext European equities transactions count
each buy and sell order as separate transactions, NYSE Euronext
U.S. equities transactions count buy and sell orders together as a
single transaction.
About NYSE Euronext
NYSE Euronext (NYX) is a leading global operator of financial
markets and provider of innovative trading technologies. The
company's exchanges in Europe and the United States trade equities,
futures, options, fixed-income and exchange-traded products. With
approximately 8,000 listed issues (excluding European Structured
Products), NYSE Euronext's equities markets - the New York Stock
Exchange, NYSE Euronext, NYSE MKT, NYSE Alternext and NYSE Arca -
represent one-third of the world’s equities trading, the most
liquidity of any global exchange group. NYSE Euronext also operates
NYSE Liffe, one of the leading European derivatives businesses and
the world's second-largest derivatives business by value of
trading. The company offers comprehensive commercial technology,
connectivity and market data products and services through NYSE
Technologies. NYSE Euronext is in the S&P 500 index. For more
information, please visit: http://www.nyx.com.
Please follow us at:
Exchanges Blog
Facebook
LinkedIn
Twitter
CAUTIONARY STATEMENT REGARDING FORWARD LOOKING
STATEMENTS
This written communication contains “forward-looking statements”
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. In some cases, you can
identify forward-looking statements by words such as “may,” “hope,”
“will,” “should,” “expect,” “plan,” “anticipate,” “intend,”
“believe,” “estimate,” “predict,” “potential,” “continue,” “could,”
“future” or the negative of those terms or other words of similar
meaning. You should carefully read forward-looking statements,
including statements that contain these words, because they discuss
our future expectations or state other “forward-looking”
information. Forward-looking statements are subject to numerous
assumptions, risks and uncertainties which change over time. ICE
Group, ICE and NYSE Euronext caution readers that any
forward-looking statement is not a guarantee of future performance
and that actual results could differ materially from those
contained in the forward-looking statement.
Forward-looking statements include, but are not limited to,
statements about the benefits of the proposed merger involving ICE
Group, ICE and NYSE Euronext, including future financial results,
ICE’s and NYSE Euronext’s plans, objectives, expectations and
intentions, the expected timing of completion of the transaction
and other statements that are not historical facts. Important
factors that could cause actual results to differ materially from
those indicated by such forward-looking statements are set forth in
ICE’s and NYSE Euronext’s filings with the U.S. Securities and
Exchange Commission (the “SEC”). These risks and uncertainties
include, without limitation, the following: the inability to close
the merger in a timely manner; the failure to satisfy other
conditions to completion of the merger, including receipt of
required regulatory and other approvals; the failure of the
proposed transaction to close for any other reason; the possibility
that any of the anticipated benefits of the proposed transaction
will not be realized; the risk that integration of NYSE Euronext’s
operations with those of ICE will be materially delayed or will be
more costly or difficult than expected; the challenges of
integrating and retaining key employees; the effect of the
announcement of the transaction on ICE’s, NYSE Euronext’s or the
combined company’s respective business relationships, operating
results and business generally; the possibility that the
anticipated synergies and cost savings of the merger will not be
realized, or will not be realized within the expected time period;
the possibility that the merger may be more expensive to complete
than anticipated, including as a result of unexpected factors or
events; diversion of management’s attention from ongoing business
operations and opportunities; general competitive, economic,
political and market conditions and fluctuations; actions taken or
conditions imposed by the United States and foreign governments or
regulatory authorities; and adverse outcomes of pending or
threatened litigation or government investigations. In addition,
you should carefully consider the risks and uncertainties and other
factors that may affect future results of the combined company, as
are described in the section entitled “Risk Factors” in the joint
proxy statement/prospectus filed by ICE Group with the SEC, and as
described in ICE’s and NYSE Euronext’s respective filings with the
SEC that are available on the SEC’s web site located at
www.sec.gov, including the sections entitled “Risk Factors” in
ICE’s Form 10-K for the fiscal year ended December 31, 2012, as
filed with the SEC on February 6, 2013, and “Risk Factors” in NYSE
Euronext’s Form 10-K for the fiscal year ended December 31, 2012,
as filed with the SEC on February 26, 2013. You should not place
undue reliance on forward-looking statements, which speak only as
of the date of this written communication. Except for any
obligations to disclose material information under the Federal
securities laws, ICE Group, ICE and NYSE Euronext undertake no
obligation to publicly update any forward-looking statements to
reflect events or circumstances after the date of this written
communication.
IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND WHERE
TO FIND IT
This communication does not constitute an offer to sell or the
solicitation of an offer to buy any securities or a solicitation of
any vote or approval. In connection with the proposed transaction,
ICE Group has filed with the SEC a registration statement on Form
S−4, which the SEC has declared effective and which contains a
joint proxy statement/prospectus with respect to the proposed
acquisition of NYSE Euronext by ICE Group. The final joint proxy
statement/prospectus has been delivered to the stockholders of ICE
and NYSE Euronext. INVESTORS AND SECURITY HOLDERS OF BOTH ICE AND
NYSE EURONEXT ARE URGED TO READ THE JOINT PROXY
STATEMENT/PROSPECTUS REGARDING THE PROPOSED TRANSACTION CAREFULLY
AND IN ITS ENTIRETY, INCLUDING ANY DOCUMENTS PREVIOUSLY FILED WITH
THE SEC AND INCORPORATED BY REFERENCE INTO THE JOINT PROXY
STATEMENT/PROSPECTUS, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO
THOSE DOCUMENTS, BECAUSE IT CONTAINS IMPORTANT INFORMATION
REGARDING ICE, NYSE EURONEXT AND THE PROPOSED TRANSACTION.
Investors and security holders may obtain a free copy of the joint
proxy statement/prospectus, as well as other filings containing
information about ICE and NYSE Euronext, without charge, at the
SEC’s website at http://www.sec.gov. Investors may also obtain
these documents, without charge, from ICE’s website at
http://www.theice.com and from NYSE Euronext’s website at
http://www.nyx.com.
NYSE
Euronext
Monthly Volume
Summary
Average Daily Volume
Total Volume Average Daily Volume
Total Volume (Unaudited; contracts in
thousands)
May-13 May-12
% Chg May-13
May-12 % Chg YTD
2013
% Chg vs.
YTD 2012
YTD 2013
% Chg vs.
YTD 2012
Number of Trading Days - European Cash 22 22 - 22 22 - 105
105 Number of Trading Days - European Derivatives 23 23 23 23 106
106 Number of Trading Days - U.S. Markets 22 22 22 22 104 104
European Derivatives Products 3,928
5,022 -21.8% 90,349 115,511
-21.8% 4,185 43.0% 443,638 41.6%
of which Bclear 769 1,995 -61.4% 17,692 45,883 -61.4% 853 -22.4%
90,422 -23.1%
Total Fixed Income Products
2,422 2,113 14.6% 55,713 48,609
14.6% 2,481 77.7% 262,949 76.0%
Short Term Interest Rate Products 2,195 1,930 13.7% 50,474
44,393 13.7% 2,295 79.1% 243,219 77.4% Medium and Long Term
Interest Rate Products 1 228 183 24.3% 5,239 4,216 24.3% 186 61.6%
19,730 60.1%
Total Equity Products 2
1,437 2,836 -49.3% 33,040 65,218
-49.3% 1,615 10.7% 171,222 9.6%
Individual Equity Products 994 2,300 -56.8% 22,856 52,890
-56.8% 1,104 8.9% 117,020 7.9% Futures 648 1,910 -66.1% 14,903
43,935 -66.1% 679 24.5% 71,945 23.3% Options 346 389 -11.2% 7,953
8,954 -11.2% 425 -9.2% 45,075 -10.1% Equity Index Products 443 536
-17.4% 10,184 12,328 -17.4% 511 14.7% 54,201 13.6% of which
Bclear 769 1,995 -61.4% 17,689 45,883 -61.4% 852 -22.5% 90,298
-23.2% Individual Equity Products 685 1,922 -64.4% 15,754 44,217
-64.4% 748 -27.2% 79,276 -27.9% Futures 619 1,858 -66.7% 14,237
42,737 -66.7% 657 -29.2% 69,590 -29.9% Options 66 64 2.5% 1,517
1,480 2.5% 91 -9.2% 9,685 -10.0% Equity Index Products 84 72 16.1%
1,934 1,667 16.1% 104 46.8% 11,023 45.4%
Commodity
Products 69 73 -5.2% 1,596
1,684 -5.2% 89 25.3% 9,467
24.2% U.S. Derivatives Products
Equity Options 3 NYSE Euronext Options
Contracts 4,348 4,204 3.4% 95,659 92,480 3.4% 4,270 4.1% 444,050
4.1% Total Consolidated Options Contracts 15,982 15,734 1.6%
351,610 346,148 1.6% 15,272 -2.3% 1,588,250 -2.3% NYSE Group
Share of Total 27.2% 26.7% 27.2% 26.7% 28.0% 1.8% 28.0% 1.8%
NYSE Liffe U.S. Futures and Futures Options Volume*
50.0 68.3 -26.8% 1,150 1,571 -26.8% 54.5 -34.8% 5,827.3 -35.4%
European Cash Products (trades in thousands)
1,404 1,612 -12.9% 30,880 35,455
-12.9% 1,407 -14.2% 147,699
-15.0% Equities 1,356 1,560 -13.1% 29,827 34,317
-13.1% 1,356 -14.5% 142,341 -15.3% Exchange-Traded Funds 13 14
-6.3% 283 302 -6.3% 14 -6.5% 1,430 -7.4% Structured Products 30 33
-9.3% 665 733 -9.3% 32 -6.3% 3,367 -7.1% Bonds 5 5 2.5% 105 103
2.5% 5 10.1% 561 9.0%
U.S. Cash Products (shares in
millions) 5 1,527 1,890 -19.2%
33,596 41,583 -19.2% 1,544
-13.9% 160,535 -13.9% NYSE Listed
(Tape A) Issues 4 Handled Volume 5 1,091 1,334
-18.2% 24,003 29,357 -18.2% 1,111 -13.2% 115,518 -13.2% Matched
Volume 6 1,051 1,266 -17.0% 23,128 27,861 -17.0% 1,069 -11.6%
111,155 -11.6% Total NYSE Listed Consolidated Volume 3,504 3,971
-11.7% 77,098 87,362 -11.7% 3,556 -8.9% 369,850 -8.9%
Share of Total Consolidated Volume Handled Volume 5 31.1%
33.6% -2.5% 31.1% 33.6% -2.5% 31.2% -1.6% 31.2% -1.6% Matched
Volume 6 30.0% 31.9% -1.9% 30.0% 31.9% -1.9% 30.1% -0.9% 30.1%
-0.9%
NYSE Arca, MKT and Regional (Tape B) Listed
Issues Handled Volume 5 247 291 -15.2% 5,430 6,406
-15.2% 238 -11.5% 24,710 -11.5% Matched Volume 6 227 262 -13.3%
4,988 5,755 -13.3% 219 -8.7% 22,773 -8.7% Total NYSE Arca & MKT
Listed Consolidated Volume 1,103 1,248 -11.6% 24,268 27,460 -11.6%
1,054 -7.9% 109,575 -7.9%
Share of Total Consolidated
Volume Handled Volume 5 22.4% 23.3% -0.9% 22.4% 23.3% -0.9%
22.6% -0.9% 22.6% -0.9% Matched Volume 6 20.6% 21.0% -0.4% 20.6%
21.0% -0.4% 20.8% -0.2% 20.8% -0.2%
Nasdaq Listed (Tape
C) Issues Handled Volume 5 189 265 -28.5% 4,163 5,820
-28.5% 195 -20.3% 20,307 -20.3% Matched Volume 6 167 228 -26.5%
3,682 5,010 -26.5% 174 -16.1% 18,131 -16.1% Total Nasdaq Listed
Consolidated Volume 1,783 1,904 -6.3% 39,234 41,886 -6.3% 1,786
-0.8% 185,705 -0.8%
Share of Total Consolidated
Volume Handled Volume 5 10.6% 13.9% -3.3% 10.6% 13.9% -3.3%
10.9% -2.7% 10.9% -2.7% Matched Volume 6 9.4% 12.0% -2.6% 9.4%
12.0% -2.6% 9.8% -1.7% 9.8% -1.7%
Exchange-Traded
Products 5,7 Handled Volume 5 233 280 -16.9%
5,124 6,163 -16.9% 225 -11.4% 23,405 -11.4% Matched Volume 6 214
251 -14.9% 4,706 5,528 -14.9% 207 -8.5% 21,579 -8.5% Total ETF
Consolidated Volume 1,060 1,237 -14.3% 23,320 27,216 -14.3% 1,016
-8.8% 105,700 -8.8%
Share of Total Consolidated
Volume Handled Volume 5 22.0% 22.6% -0.6% 22.0% 22.6% -0.6%
22.1% -0.6% 22.1% -0.6% Matched Volume 6 20.2% 20.3% -0.1% 20.2%
20.3% -0.1% 20.4% 0.1% 20.4% 0.1% 1 Data includes
currency products.
2
Includes all trading activities for Bclear, NYSE Liffe's clearing
service for wholesale derivatives. 3 Includes trading in U.S.
equity options contracts, not equity-index options. 4 Includes all
volume executed in NYSE Group crossing sessions. 5 Represents the
total number of shares of equity securities and ETFs internally
matched on the NYSE Group's exchanges or routed to and executed at
an external market center. NYSE Arca routing includes odd-lots. 6
Represents the total number of shares of equity securities and ETFs
executed on the NYSE Group's exchanges. 7 Data included in
previously identified categories. * ADVs calculated with the
appropriate number of NYSE Liffe U.S. trading days. Source: NYSE
Euronext, Options Clearing Corporation and Consolidated Tape as
reported for equity securities. All trading activity is
single-counted, except European cash trading which is double
counted to include both buys and sells.
Grafico Azioni NYSE Group (NYSE:NYX)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni NYSE Group (NYSE:NYX)
Storico
Da Lug 2023 a Lug 2024